医学
痴呆
疾病
神经保护
退行性疾病
人口
人口老龄化
变性(医学)
老年学
神经退行性变
流行病学
退行性疾病
帕金森病
认知功能衰退
疾病负担
环境卫生
神经科学
老年人
公共卫生
阿尔茨海默病
肌萎缩侧索硬化
中枢神经系统
精神科
老年人
神经元变性
帕金森病
脑老化
作者
Vishesh Kumar,Shiv Charan,Ajay Prakash,Bikash Medhi
出处
期刊:International journal of pharmaceutical sciences and nanotechnology
[BSP Books Private Limited]
日期:2025-12-31
卷期号:18 (6): 8319-8325
标识
DOI:10.37285/ijpsn.2025.18.6.1
摘要
Neurodegenerative disorders (NDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and many more, are progressive diseases that ultimately result in degeneration and dysfunction of the central nervous system (CNS). They are characterized by a progressive degeneration of neurons and their processes, causing cognitive impairment, motor inabilities, and ultimately, death. The burden of neurodegenerative diseases is increasing worldwide, and the World Health Organization (WHO) has predicted that the prevalence of dementia alone will reach more than 150 million worldwide by 20501. Similar trends are evident in India, where recent large-scale studies report that 7.4% of adults aged 60 years and above approximately 8.8 million people are currently living with dementia2. National-level analysis employing an artificial-intelligence-based methodology estimated a slightly higher burden, with dementia prevalence at 8.44%, corresponding to nearly 10.08 million older adults. Projections indicate that, with continued population aging, the number of dementia cases in India may rise to approximately 16.9 million by 20363. These statistics highlight the rapidly increasing public-health impact of neurodegenerative disorders in India, driven by demographic shifts, lifestyle factors, and increased exposure to environmental risks.
科研通智能强力驱动
Strongly Powered by AbleSci AI